Beruflich Dokumente
Kultur Dokumente
ANovaLeidosEnsaiosClnicos
PSGRADUAOSOBREDIREITODOMEDICAMENTO
AnaMariaNogueira
19fevereiro2015
EnsaiosClnicos
Contexto Regulamentar
PSGRADUAOSOBREDIREITODOMEDICAMENTO
AnaMariaNogueira
19fevereiro2015
2/19/2015
2/19/2015
EnsaiosClnicos
2/19/2015
EnsaiosClnicos
Placebo
EnsaiosClnicos
Aleatorizao
2/19/2015
EnsaiosClnicos
Ocultao
While, in general, doubleblind designs are considered optimal (), this paradigm may
distort one of the fundamental objectives of phase III studies to compare a new regimen
with the existing standard under realistic clinical conditions
JournalofThrombosisandHaemostasis,6:227229,2007
9
10
2/19/2015
12
2/19/2015
ClinicalTrialsDirective
2001/20/EC
ThemostheavilycriticizedpieceofEUlegislationintheareaofpharmaceuticals.
Thenumberofapplicationsforclinicaltrialsfellby25%(2007to2011)
Thecostsforconductingclinicaltrialshaveincreased.
Staffneedsforindustrysponsorstohandletheclinicaltrialauthorizationprocess
havedoubled (107%);
Administrativecostsincreased98%increasefornonindustrysponsors
Insurancefeeshaveincreasedby800%forindustrysponsors.
Theaveragedelayforlaunchingaclinicaltrialhasincreasedby90%to152days.
14
2/19/2015
15
16
2/19/2015
17
PwC/APIFARMA
EnsaiosclnicosemPortugal|Apresentaodosresultadosdoestudo
18
2/19/2015
30%Investimentoperdido!
25M
30%Doentesnoincludos!
1.699
19
20
10
2/19/2015
21
22
11
2/19/2015
TheInnovationGap
LongDevelopmentTimes+LowSuccessRates=HighR&DCosts
23
1950
2015
2050
24
12
2/19/2015
25
26
13
2/19/2015
27
StrategicResearchAgendaforInnovativeMedicinesInitiative2
28
14
2/19/2015
29
30
15
2/19/2015
31
32
16
2/19/2015
33
34
17
2/19/2015
Sustainable
Financing
Byensuringuptakeof
innovationEuropehasthe
potentialtofurtherimprove
healthoutcomesandwealth
creation
Appropriateuseof
innovativemedicinesis
essentialtoensuringa
sustainablehealthbudget
Growth &
Competitiveness
Pharmacouldhaveavital
roleinEuropesgrowthand
futurecompetitiveness
Source:EFPIA.Health&GrowthEvidenceCompendium(2014)
35
ObjectivesoftheEurope2020andHorizon2020initiatives
Source:EuropeanCommission:Europe2020(2012);EuropeanCommission:Research&Innovation Horizon2020(2012)
36
18
2/19/2015
37
38
19
2/19/2015
39
It was the best of times, it was the worst of times, it was the
age of wisdom, it was the age of foolishness, it was the epoch of
belief, it was the epoch of incredulity.
Charles Dickens
40
20
2/19/2015
41
42
21
2/19/2015
43
44
22
2/19/2015
BenefciosparaaparaasInstituies&Academia
Melhoriadaqualidadeassistencial
Promoodoconhecimentoedesenvolvimentocientfico;
Retenoeestmuloainvestigadoresnareadasade;
Potenciaodacriarnovasparceriasentreempresas,unidadesdesadee
centrosdeinvestigao,permitindoestimularevalorizaraexcelnciacientfica
doPas;
Melhoriadavisibilidadeecompetitividadeanvelnacionaleinternacional,
proporcionadomaiorparticipaoematividadesinternacionais;
Contributoefetivoparaacriaoderiquezaparaopas.
45
BenefciosparaosDOENTES
AcessoPrecoceaNovoseMelhoresMedicamentos
MelhorEducaoemSade
MelhoriadaQualidadeAssistencial
Papelactivo noDesenvolvimentodeNovasMolculas
46
23
2/19/2015
BenefciosparaaIndstriaFarmacutica
47
Formaoprepsgraduadaeminvestigaoclnica
ValorizaocurriculardaInvestigaoClnica
OrganizaoeLideranaInstitucional
Definioecomunicaodeprioridadesestratgicas
Definio,comunicaoecumprimentodemtricas
InformatizaodeRegistosClnicos
Controloegestofinanceira
Condiestcnicasnoscentros
AlocaodeRecursosHumanosdedicados
48
24
2/19/2015
Behavior
Engine
Catalyzing
Engine
Execution
Engine
49
na arte
50
25
2/19/2015
(MORE!) try
DoorDoNot.Thereisno
Yoda
51
26